Further, there is evidence of AD-related pathology in patients with epilepsy including accumulation of β-amyloid (Aβ) (3, 4, 21–23) and tau (3, 4, 23), and the APOE4 genotype has been liked to an increased risk of developing epilepsy (24, 25). Here, MAPT is linked to epilepsy.